Ibrutinib improves survival for relapsed or refractory chronic lymphocytic leukemia (CLL) after first-line chemoimmunotherapy: population-based outcomes from 677 patients treated in British Columbia (BC)

著录项

• 来源
  《Leukemia and lymphoma》 |2020年第s1期|共3页
• 作者

  Gerrie Alina S.; VanderVeer Elysha; Huang Steven; Lee Lauren; Bruyere Helene; Gillan Tanya; Li Charles; Ramadan Khaled; Villa Diego; Scott David; Connors Joseph M.; Sehn Laurie; Toze Cynthia;

  展开▼
• 作者单位

  BC Canc Vancouver BC Canada;

  Univ British Columbia Vancouver BC Canada;

  Leukemia BMT Program BC Vancouver BC Canada;

  BC Canc Surrey Mem Hosp Vancouver BC Canada;

  Vancouver Gen Hosp Cytogenet Lab Vancouver BC Canada;

  Mem Univ St John NF Canada;

  Univ British Columbia Vancouver BC Canada;

  St Pauls Hosp Vancouver BC Canada;

  BC Canc Ctr Lymphoid Canc Vancouver BC Canada;

  BC Canc Ctr Lymphoid Canc Vancouver BC Canada;

  BC Canc Ctr Lymphoid Canc Vancouver BC Canada;

  BC Canc Ctr Lymphoid Canc Vancouver BC Canada;

  Leukemia BMT Program BC Vancouver BC Canada;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词